Objective: To evaluate th e role o f com ple m ent factor C5 in a m odel o f zym osan-induced m ultiple organ dysfunction syndrom e. Design: E xperim ental anim al study. Setting: Central anim al laboratory of a u n i versity hospital. Subjects: Twenty-five C 5-deficient B2D10/ Old and 25 C5-sufficient B2D10/New m ice. Interventions: On day 0, all m ice received an in tra p erito n ea l in je ctio n w ith zym osan suspended in paraffin in a dose of 1 mg/g body w eight. Measurements and Main Results: B etw een days 0 and 12, b iological param eters (tem per ature, body w eight, and clin ica l condition) w ere m easured daily and m ortality w as m oni tored. C linical con d ition w as assessed as a symptom score by b lin d ly grading th e degree o f leth a rg y , c o n ju n c tiv itis , d ia rrh ea , and ruffled fur of each m ouse on a 2-point scale (maximum score o f 4). On day 12, all surviving m ice w ere k illed and relative organ w eigh ts o f lungs, liver, spleen, and kidneys w ere cal culated. R elative organ w eigh t was defined as (organ w eight/body w eight) x 100%. Zymosan adm inistration induced a typical triphasic illness. D eterioration o f the clin ical condition, as indicated by the symptom score, and the decrease in tem perature and body w eight in the acute phase w ere all sig n ifi cantly less severe in C 5-deficient m ice (p < .005). In the late phase, no differences could be noticed in th e courses o f these biological From the param eters. O verall m ortality w as 2 (8%) o f 25 in C 5-deficient m ice and 8 (32%) of 25 in 05su fficien t m ice (p = .049), a difference that was m ainly due to a difference in th e acute phase. Organ dam age, assessed as th e relative organ w eights, did n ot show any sta tistica l differ ences for any organ b etw een both strains. Conclusions: Com plem ent factor C5 appears to play an im portant role in th e acute hyper dynam ic sep tic response in th is m odel. How ever, d eficien cy o f C5 could n ot prevent organ dam age in the late m u ltip le organ dysfunc tion syndrom e phase. This fin din g su ggests that other factors m ust be m ore im portant in the developm ent o f th e inflam m atory response lead in g to m u ltip le organ d ysfunction syn drome. (Crit Care Med 1995; 23:1686-1693) Key Words: com p lem en t 5a; d isea se m odels, anim al; zym osan; m ortality; ad u lt resp iratory d istr e ss syndrom e; m u ltip le organ failu re; sepsis; inflam m atory resp on se; critica l illn ess
The complement system consists of at least 25 plasma proteins, formed by the liver and macro phages (4, 8-10). Two pathways of complement acti vation currently are recognized: the classical path way, which is activated by antigen-antibody complexes (11), and the alternative pathway, which is activated by foreign material and tissue injury (12). Both pathways converge at the breakdown of C3, the subsequent cleavage of C5, and the activa tion of the final common pathway (3, 4). C5 is divided enzymatically into C5a and C5b. C5a is both an anaphylatoxin and a chemotactic agent. The latter function is probably the most important since C5a is rapidly converted into C5a desarginine (des Arg), with concomitant loss of its anaphylatoxic activity. Its chemotactic activity stimulates activa tion, aggregation and adherence of polymorpho nuclear granulocytes to the endothelium with sub sequent degranulation and release of oxygen radicals (13), vasoactive substances, and a variety of proteinases which can cause endothelial damage (3,14, 15), resulting in generalized edema. The chemotac tic activity of C5a and C5a des Arg is specifically enhanced by Gc-globulin and is inactivated by chemotactic factor inactivator (16, 17). Proinflammatory cells possess a receptor for C5a (18). In addition to many inflammatory functions, C5a also has immunoregulatory activities. For example, C5a induces the release of interleukin (IL)-6 by some (mainly B-glucan and a-mannan) teins, 7% lipids, an Classically, zymosan components (31). complement (32). Unopsonized zymosan also stimulates macro phages to the release of various inflammatory me diators (33). The interaction between zymosan and macrophages appears to be mediated by three classes of cell surface receptors, namely, the mannose/ fucose receptor (34), the |3~glucan receptor (35), and the CR3 (CDllb/CD18) receptor (36).
In this model, interruption of complement activation could theoretically lead to an attenuation of the in flammatory response which leads to the development of multiple organ dysfunction syndrome.
In used C5mice developm ent of multiple organ dysfunction syndrome.
MATERIALS AND METHODS
Zymosan. Zymosan A (Sigma Chemicals, St. Louis, MO) was irradiated with 5 kGy and suspended (2.5 g/100 mL) by high frequency vibration in liquid paraffin, for 60 mins at 40°C. This suspension was sterilized by incubation in a waterbath at 100°C for stimulated monocytes (19-21) and stimulates the 80 mins. Sterility was confirmed by aerobic incubaproduction of IL-1 after binding to macrophages (19, 22). tion on blood-agar plates for two days at 37°C. Before utilization, the zymosan was warmed to 40°C C5b participates together with C6, C7, C8, and C9 in the formation of the terminal complement complex. The terminal complement complex exists in two analogous forms. One form exists in a fluid phase in combination with the S-protein: this com plex is nonlytic, and can be detected in plasma and inflammatory fluids (19, 22-24). The other form is the membrane attack complex, which can cause cell-lysis by penetrating lipid membranes such as the endothelium (25). Excessive complement acti vation can thus result in a generalized endothelial damage with a subsequent generalized permeability edema and organ injury (13).
We have developed a model of multiple organ dysfunction syndrome in which an intraperitoneal injection of zymosan suspended in paraffin leads to a generalized inflammatory response and histo pathologic changes closely resembling the clinical entity of multiple organ dysfunction syndrome (26). This model has been validated in our laboratory and by others (27-30). Zymosan is a particulate cell wall product of the yeast, Saccharomyces cerevisiae, and vibrated in a high-frequency waterbath for 15 mins.
Animals. B10D2/01d.Sn and B10D2/New.Sn mice were obtained from Jackson Laboratories (Bar Har bor, ME) and from Harlan Olac Limited (Bicester, UK), respectively. B10D2/01d.Sn mice are congeni tally CS-deficient by a deletion mutation on chro mosome 2 (37), The B10D2/New.Sn mouse is the coisogenetic twin of the B10D2/01d.Sn mouse, but without the mutation on chromosome 2 (37), C5 deficiency in B10D2/01d.Sn mice was shown to be accompanied by an almost complete absence of hemolytic complement activity (38). Only male mice were used, because female mice were reported not to be consistent in their C5 concentrations (39).
Throughout the experiment, all mice were al lowed free access to water acidified with hydrochlo ric acid to a pH of 3 and were fed standard labora tory chow (RMH-GS pellets, Hope Farms, Woerden, The Netherlands) irradiated at 10 kGy. Room tem perature was kept constant at 21°C and a 12-hr lighting cycle was maintained. The experiments Experimental Design. Twenty-five C5-deficient mice (B10D2/01d.Sn.), 14 wks old and weighing 19 to 32 g, and 25 control mice (B10D2/New.Sn.), 12 wks old and weighing 22 to 29 g, were adapted to handling 2 wks before the start of the experiment. On day 0 of the experiment, all mice received an aseptic intraperitoneal injection of zymosan in a dose of 1 mg/g body weight. Between days 0 and 12, body temperature, body weight, and clinical condi tion were measured and monitored daily. Clinical condition was assessed as a symptom score by grad ing the severity of conjunctivitis, diarrhea, ruffled fur, and lethargy in a blinded fashion on a 2-point scale (0 = none, 1 = present; minimum = 0, maxi mum = 4). Mortality rate was monitored daily. On day 12 , all surviving mice were anesthetized with ether and bled by retro-ocular puncture. The abdo men was opened, using a sterile technique, and samples of the peritoneal fluid were collected for aerobic and anaerobic culture on blood-agar plates for 2 days at 37°C. Subsequently, lungs with tra chea, spleen, liver, and kidneys were inspected, dissected free, and weighed.
Relative organ weights were calculated using the formula: (organ weight/body weight) x 100%. In mice that died prematurely before day 12, no anaero bic cultures were performed from the peritoneal fluid because post mortem anaerobic overgrowth could be expected.
Statistical Analysis. Statistical analysis of bio logical parameters (body temperature, body weight, and symptom score) was performed using the distribution-free curve analysis according to Koziol et al (40). Since the zymosan-induced illness is charac terized by distinct phases, comparisons were made both for the acute phase (days 0 to 4), and the late phase (days 8 to 12). Relative organ weights were compared, using the distribution-free Wilcoxon's two sample test. Noncontinuous data (mortality rate) were analyzed, using Fisher's exact test. Differ ences between groups were considered to be statis tically significant at p < .05. Figure 1 as the course of the symptom scores. In the acute phase (days 0 to 4), the mice became lethargic and anorectic, hyperventilated, lost hemorrhagic fluid from the nose and conjunctivae, and had diarrhea. According to the symptom score, C5-deficient animals dis played significantly less severe (p < .0001) symp toms than C5-sufficient mice. After 3 days, the con dition of the surviving mice improved: they became more active, showed no signs of conjunctivitis or diarrhea, and their fur was only slightly ruffled. Recovery of C5-deficient mice appeared to be quicker. However, after 8 days, the clinical condition of the mice deteriorated progressively. They became more lethargic and started to lose hemorrhagic fluids from the nostrils and conjunctivae. C5-deficient mice deteriorated significantly slower (p < .0001) than their C5 sufficient controls. Figure 1 shows that body temperature declined dramatically in C5-sufficient mice the first day af ter zymosan injection. C5-deficient mice, however, showed little decrease (p < .001) in temperature. After a recovery phase, temperature decreased again in the late phase. At this time no significant differ ences were noticed between the two groups.
RESULTS

Biological Measurements. Intraperitoneal admin istration of zymosan induced a typical triphasic clinical illness, depicted in
The course of body weight was also triphasic, as shown in Figure 1 . Body weight decreased in the acute phase. Recovery in C5-deficient mice was sig nificantly better (p < .0001) than in the OS-suffi cient controls. After this recovery phase, body weight decreased again in both groups, with a less serious decrease in C5-deficient mice. However, this differ ence did not reach statistical significance (p = .0552).
Survival Rates, Survival rates for both groups are depicted in Figure 1 . In the acute phase, seven C5-sufficient mice died vs. one C5-deficient mouse. No mice died in the recovery phase. In the late phase, one mouse died in each group. Overall mor tality was 8% (two of 25) in C5-deficient mice and 32% (8 of 25) in C5-sufficient controls (p = .049), due mainly to the difference observed in the acute phase.
Macroscopic Appearance of the Organs and Rela
tive Organ Weights. After samples of the peritoneal fluid had been taken for anaerobic and aerobic bac terial cultures, the organs were dissected free and inspected. The organs of the mice that died in the acute phase showed little abnormalities. The lungs were hyperemic and the abdomen showed few or no adhesions. No differences were noticed between groups.
The lungs of mice that died in the late phase or that were killed on day 12 were extremely hyperemic, with hemorrhagic spots, and occasion ally, extensive hemorrhagic infarction. The abdo men showed signs of an extensive fibroplastic peri tonitis with massive adhesions.
Although the C5-sufficient control mice showed the most extensive macroscopic abnormalities, no significant differences were found with the C5~ deficient mice (data not shown). Organ damage of the surviving mice, assessed as the increase in relative organ weights of lungs, liver, spleen and kidneys is depicted in Figure 2 . No significant differences were found between the two strains.
Bacteriology. All cultures of the peritoneal fluid of the surviving mice were sterile, thereby indicating the absence of bacterial peritonitis. concentrations (25, 41) . Other stud ies (42, 43) could not confirm that the severity or mortality of sepsis is correlated with a persistent increase in C5a concentrations. On the other hand, a strong correlation was found between increased plasma concentrations of C5a and the development of ARDS (44), while C5a concentrations correlated with the severity of pulmonary failure (4-5). It also has been demonstrated that C5a is increased in bronchoalveolar lavage fluid in patients developing ARDS, with a normalization after ARDS had re solved (16). Chemotactic factor inactivator, which decreases C5a-directed neutrophil chemotaxis, has been shown to be markedly increased in ARDS bronchoalveolar lavage fluid. However, chemotactic factor inactivator-functional activity was markedly decreased, suggesting that patients with ARDS are functionally deficient in chem otactic factor inactivator, with a subsequent increased ability of C5a to attract neutrophils (46). Plasma terminal complement complex concentrations have been shown to be increased 2 days before the onset of ARDS in septic patients and to be decreased imme-lesser extent, C5a des Arg, are relatively unstable molecules C5a from serum Furthermore, C5a des Arg is rapidly bound and removed from plasma by neutrophils (51). The con flicting results concerning the correlation between septic shock, ARDS, and multiple organ dysfunc tion syndrome, and the activation of C5a might be explained by this observation.
DISCUSSION
Both clinical and experimental data have sug gested a relationship between activation of the complement system and the pathogenesis of septic
In order to find a possibl* between complement activati ment of septic shock. ARDS, causal relationship multiple syndrome, experiments formed with complement depletion and, more spe cifically, C5 depletion by using C5-deficient animals or using antibodies against C5a. In a porcine endotoxic shock model (52), complement depletion with Naja haje cobra venom factor significantly improved cardiac index and visceral perfusion. In another porcine model (53) using a continuous infusion with In another study (57), it was demonstrated that C5deficient mice were protected from combined tumor necrosis factor-endotoxin-induced mortality, shock, hypothermia, hemoconcentration and bowel injury. The latter study (57) also showed the importance of C5 since C3-deficient mice were not protected. The present study shows that C5-deficient mice displayed an attenuated response in the acute hy perdynamic septic phase, as measured by the re-C5a is not the decisive factor associated with the development of multiple organ dysfunction syndrome in this model, and that other factors such as macro phage activation may be more important in this respect. Clinical indications, suggesting the impor tance of macrophage activation, are the association between neopterin concentrations and a poor out come in sepsis and multiple trauma patients (60, 61). Neopterin is a stable inactive end product of macrophage metabolism and a marker of macro phage activity, A recent study (50) has shown that early after severe blunt trauma, neopterin/creati nine ratios were not significantly higher in patients developing multiple organ dysfunction syndrome. However, from 8 days after trauma, these ratios were significantly higher in those patients. This finding suggests that a late activation of macro phages is associated with the development of mul tiple organ dysfunction syndrome. In the TNFendotoxin-model, C5-deficient mice were protected duction in the symptom score, hypothermia, and from TNF-endotoxin effects. However, when the decrease in body weight. Overall mortality was re duced, but this reduction was mainly due to a de crease in the acute phase. This finding suggests TNF dose was increased, no protection occurred, suggesting that high doses of TNF act independent of the complement system (57). This finding shows that C5a might be an important mediator in the acute hyperdynamic septic response in this model. This conclusion is in agreement with the above mentioned clinical studies in which a possible rela tionship is suggested between C5a activation and that experimentally, other, more potent factors could be implicated in the pathogenesis of multiple organ dysfunction syndrome. Further support for this hy pothesis comes from the fact that in our model, mortality could be reduced by elimination of liver septic shock. It is also in line with the reported attenuation of the acute response in experimental studies with cecal ligation and puncture and TNF-and splenic macrophages with liposome encapsu lated dichloro-methylene-diphosphonate before zy mosan administration, suggesting that macrophage or endotoxin-induced sepsis. It has been suggested activation is also an important mediator (62). that C5a modulates the endotoxin-triggered TNF response. Endotoxin administration in CS-deficient mice resulted in markedly lower serum TNF-activ ity when compared with Cö-sufficient mice (58). Since TNF production has been documented in the acute phase of our model, and pretreatment with anti-TNF antibodies could attenuate the acute re-We thus conclude that C5 deficiency attenuates the acute hyperdynamic response, but does not pre vent organ damage in a model of zymosan-induced generalized inflammation. Thus, C5 is not the only factor involved in the late inflammatory response leading to multiple organ dysfunction syndrome. sponse (59), the attenuation seen in C5-deficient mice could be TNF-mediated. However, late organ damage, as measured by the relative organ weights, was not reduced, suggesting that C5a might not be an important mediator in the late hypodynamic phase of this model. This finding is in agreement with the few clinical studies in which no relationship could be found between C5a activation and multiple organ dysfunction syndrome (5, 6) . It is also in line with the studies done in the cecal ligation and punc ture model where overall mortality did not decrease despite a decrease in acute mortality (37).
Since zymosan is also an important stimulator of macrophages (33), we hypothesize that activation of
